![Australian Securities Exchange / Economy of New South Wales / Proxy voting / Business / Ordinary resolution / Economy of Australia / Corporations law / Business law / Law Australian Securities Exchange / Economy of New South Wales / Proxy voting / Business / Ordinary resolution / Economy of Australia / Corporations law / Business law / Law](https://www.pdfsearch.io/img/f8190953bd3d1aa68fd1e9c3f02ef1fe.jpg)
| Document Date: 2014-04-13 21:12:40 Open Document File Size: 152,10 KBShare Result on Facebook
City Sydney / / Company Benitec Biopharma Limited / / Country United States / Australia / / Currency USD / / / Event Funding / Company Listing Change / / IndustryTerm licensed ddRNAi technology / biopharmaceutical / biotechnology / gene‐silencing technology / / MedicalCondition oculopharyngeal muscular dystrophy / resistant lung cancer / cancer / retinitis pigmentosa / macular degeneration / Huntington’s disease / Hepatitis C / Hepatitis B / pain / HIV/AIDS / / Person Peter French / Carl Stubbings / Jane Lowe / / / Position CEO / Chief Business Officer / General / / Technology licensed ddRNAi technology / gene‐silencing technology / biotechnology / / URL www.benitec.com / /
SocialTag |